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ABSTRACT
The Circulatory Risk in Communities Study (CIRCS) is an ongoing community-based epidemiological study of lifestyle-related
disease involving dynamic prospective cohorts of approximately 12,000 adults from ﬁve communities of Japan: Ikawa, Ishizawa
and Kita-Utetsu (Akita Prefecture), Minami-Takayasu (Osaka Prefecture), Noichi (Kochi Prefecture), and Kyowa (Ibaraki
Prefecture). One of the most notable features of CIRCS is that it is not only an observational cohort study to identify risk factors
for cardiovascular diseases (CVD), such as stroke, coronary heart disease, and sudden cardiac death, but it also involves prevention
programs for CVD. Using basic, clinical, epidemiological, and statistical techniques, CIRCS has clariﬁed characteristics of CVD
and the related risk factors to develop speciﬁc methodologies towards CVD prevention in Japanese middle-aged or older adults for
more than half a century.
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ORIGIN OF THE COHORT
The Circulatory Risk in Communities Study (CIRCS) is an
ongoing community-based epidemiological study using dynamic
prospective cohorts involving approximately 12,000 persons
per 4-to-6-year period (more than 65,000 people in total) in
ﬁve Japanese communities: (1) Ikawa in Akita Prefecture
(northeastern rural community); (2) Ishizawa and Kita-Utetsu,
Honjo (presently Yuri-Honjo) City in Akita Prefecture (north-
eastern rural communities); (3) Minami-Takayasu, Yao City in
Osaka Prefecture (mid-western suburban community); (4) Noichi,
Konan City in Kochi Prefecture (western rural community); and
(5) Kyowa, Chikusei City in Ibaraki Prefecture (mid-eastern rural
community) (Figure 1).
In 1963, Dr. Yoshio Komachi, a physician and epidemiologist
of the Osaka Medical Center for Cancer and Cardiovascular
Diseases (presently Professor Emeritus of the University of
Tsukuba), launched demonstrative surveys to reveal which
lifestyle activities, especially those related to traditional Japanese
lifestyle, were adversely associated with stroke, the leading cause
of death in Japan in the 1960s, and also how to prevent it.1
Komachi and his colleagues started a comparative survey
between communities in Akita and Osaka, where, nationally,
mortality from stroke had been the highest and lowest,
respectively. In 1969, they added the community of Noichi and,
in 1981, they added the community of Kyowa as new survey
ﬁelds. The surveys have been conducted annually, and the
survey methods have been uniﬁed across those communities.
The annual surveys and follow-up work in Ishizawa=Kita-Utetsu
and Noichi terminated in 1987 and 2005, respectively.
Community registration of stroke and coronary heart disease
and mortality surveillance has been done for more than 55 years.
Since 1999, registration was started for disabling dementia, based
on the Japanese Long Term Care Insurance system.
In the initial ecological and cross-sectional studies by Komachi
and his colleagues, which compared the incidence of stroke and
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coronary heart disease between rural Akita and suburban Osaka,
they found that the incidence of stroke (especially that of cerebral
hemorrhage), blood pressure levels, and salt intake were much
higher in Akita, while the incidence of coronary heart disease,
serum total cholesterol levels, and fat and protein intakes were
lower. They observed that the lifestyle of people in Akita in the
1960s and 70s was characterized by a high consumption of
traditional Japanese foods, such as a large intake of rice, miso
soup, salt-preserved ﬁsh, pickles, soy sauce, and salt, and a small
intake of animal products, as well as heavy agricultural work.
Among traditional Akita farmers, lean middle-aged men were
more likely to suﬀer from stroke. Based on their observations,
Komachi and his colleagues hypothesized that the most important
determinant of stroke was hypertension and not hyperlipidemia or
diabetes in Japanese. They also hypothesized that the association
between serum total cholesterol levels and cardiovascular disease
(CVD) may not be linear, and that very low cholesterol levels, as
well as very high blood pressure levels, would carry an adverse
impact on risk of stroke, especially intraparenchymal hemor-
rhage. They also found that high cholesterol levels are positively
associated with risk of coronary heart disease, conﬁrming the
ﬁndings of previous frontier studies: the Minnesota Business and
Professional Men’s,2 Framingham Heart,3 and Seven Countries
studies.4
Komachi’s U-shaped hypothesis caused strong debate, coming
under criticism from some western researchers who suggested
that the Japanese physicians may have misdiagnosed coronary
heart disease as stroke. They also questioned the accuracy of
measurement of the serum total cholesterol. In response, Komachi
and his colleagues, as well as the Hisayama Study group,
demonstrated that stroke diagnosis was validated using autopsy
ﬁndings.5,6 They standardized the epidemiological criteria of
stroke and coronary heart disease according to the World Health
Organization (WHO) criteria7 since the 1960s, and have used the
ﬁndings of computed tomography (CT)=magnetic resonance
imaging (MRI) for the detailed classiﬁcation of stroke types
since the 1980s.8,9 In 1975, their lipid laboratory participated in
the CDC-NHLBI Lipid Standardization Program of the United
States’ Centers for Disease Control and Prevention (CDC) and
National Heart, Lung, and Blood Institute (NHLBI), and since
then the laboratory has become well-known for its accuracy and
precision.10 From 1992, the laboratory became a member of the
Cholesterol Reference Method Laboratory Network (CDC=
CRMLN).
The U-shape hypothesis gained wider acceptance after 1989
through the publication of a prospective study conducted in
Akita as a part of CIRCS,11 and a cohort study, the Multiple Risk
Factor Intervention Trial (MRFIT), in the United States,12 which
independently showed the inverse association between low total
cholesterol levels and risk of intraparenchymal hemorrhage.
Following these reports, the NHLBI held an international
conference on low blood cholesterol in 1990 to review and
discuss existing data on the U-shaped relationship between total
cholesterol levels and mortality from CVD and other causes from
19 cohort studies worldwide.13 The inverse association between
the total or low-density lipoprotein (LDL) cholesterol levels and
risk of intraparenchymal hemorrhage has since been repeatedly
replicated in meta-analyses and cohort studies.14
The study name ‘CIRCS’ was ﬁrst used in 2008, before which
there was no speciﬁc study name; sometimes it was referred to as
the ‘Akita-Osaka Study’15 or ‘Osaka Medical Center Study’.16 To
search the PubMed database for CIRCS papers published on or
before 2008, it is useful to use the phrase: “Shimamoto T and
Tsukuba”. The key features of CIRCS have previously been
introduced in the literature.17,18
CIRCS has been conducted as a part of community prevention
program and has, therefore, been sponsored mainly by each local
municipality. Osaka Prefecture, the Ministry of Education,
Culture, Sports, Science and Technology, the Ministry of Health,
Labour, and Welfare, and other relevant organizations have also
supported CIRCS.
SCOPE AND FEATURES
CIRCS is one of the oldest epidemiological studies of CVDs
in Japan. When CIRCS was ﬁrst started in the 1960s, strategies
for prevention of CVDs, especially of stroke, were not yet
established in Japan. The public health mission of CIRCS was
to ﬁnd out ways to improve stroke prevention in community
settings. A systematic mass screening was begun, which
constituted measurements of blood pressure, electrocardiogram,
ocular funduscopy, and blood test, all of which were not
commonly carried out at that time, and the technique for physical
examination of the general population had also not yet been
established. CIRCS strictly standardized each test as an exposure
factor according to international standards. Participants were
interviewed about lifestyle-related factors, such as employment,
smoking, alcohol, diet, and physical activity. The main outcome
measures were incidence of stroke (intraparenchymal hemor-
rhage, subarachnoid hemorrhage, and cerebral infarction),
coronary heart disease (myocardial infarction, eﬀort angina
pectoris, and sudden cardiac death), and dementia. Based on
CT=MRI imaging, cerebral infarction was further classiﬁed in
subtypes (lacunar, large-artery occlusive and embolic infarctions).
CIRCS is composed of several community-based cohorts with
diﬀerent lifestyles and living environments, which makes it
possible to compare incidence of CVD and its risk factors to
Minami-Takayasu, Osaka
Kyowa, Ibaraki
Ikawa, Akita
Ishizawa and Kita-Utetsu, Akita
Noichi, Kochi
Figure 1. Location of study ﬁelds of the CIRCS
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identify diﬀerent or common features among the participating
communities and to clarify the characteristics of CVD in Japan.
CIRCS has a number of other important characteristics. First,
as well as the hard endpoints mentioned above, through its annual
surveys CIRCS has been used to identify intermediate outcomes,
including hypertension, diabetes mellitus, atrial ﬁbrillation,
chronic kidney disease, and gout. Second, repeat measures or
trajectory analyses can be done based on annual survey data.
Third, dietary information, based on 24-hour dietary recall, is
available. Fourth, data from over more than 5 decades can be
analyzed. Finally, serum samples dating back from the 1980s
have been stored and are available for research.
Building and maintaining the cohort
The ﬁrst survey was conducted in 1963 and included the
following examinations: medical history, height, weight, blood
pressure, physical examination, urinalysis, laboratory measure-
ments of serum total cholesterol and protein, electrocardiogram,
color photographs of the right ocular fundus, and an interview for
assessing lifestyle factors.11 This examination system was novel
in Japan at that time. These ongoing surveys, alongside some
additional examinations, have been conducted annually with the
aim of ﬁnding of novel risk factors and measures for prevention
of CVD.
There follows a brief description for each of the major
examinations. (1) Trained physicians, nurses, or technicians
measured systolic and ﬁfth-phase diastolic blood pressures using
a standard mercury sphygmomanometer placed on the right arm
of the participants who had been resting for at least 5 minutes
prior to the measurement. (2) Blood samples were collected while
the participants were quietly seated. The blood was drawn into
siliconized vacuum tubes and was generally kept standing for 10
to 30 minutes at room temperature to let the blood clot before
being centrifuged at 1,300 to 1,500 × g for approximately 15
minutes. The serum was separated and stored at −80°C awaiting
laboratory analyses. As examples of the laboratory analyses
performed, serum total cholesterol was measured using the Zac-
Henly method from 1963 to 1974, the Liebermann-Burchard
direct method from 1974 to 1986, and the enzymatic method from
1986 to the present. Glucose was measured using the cupric-
neocuproine method from 1975 to 1986, the hexokinase method
from 1986 to 1993, the glucokinase method from 1993 to 2001
period, and the hexokinase method from 2001 to the present. All
blood samples were measured using standardized protocols at
the laboratory of the Osaka Medical Center for Health Science
and Promotion (currently, the Osaka Center for Cancer and
Cardiovascular Disease Prevention); and this consistence over
a 55-year period has allowed for the investigation of long-term
trends. (3) Electrocardiogram was measured in the supine
position. Two physicians independently coded each record of
electrocardiogram, based on the Minnesota Code. If the codes
were in agreement, they were accepted, while disputed codes
were discussed by the two physicians, and if necessary, a third
experienced physician arbitrated. (4) Color photographs taken of
the right ocular fundus were independently read and coded by
two trained physicians using a modiﬁed Scheie classiﬁcation.
Agreement and disagreement over classiﬁcations were dealt with
in the same manner as described for electrocardiograms.
With regard to stroke and coronary heart disease registration,
CIRCS investigated the following ascertainment sources in
addition to all hospitalized cases: baseline surveys, death
certiﬁcates, ambulance records, national insurance claims, and
reports from local physicians, public health nurses, and health
volunteers. In order to validate the diagnoses, all living patients
were either visited or invited to baseline surveys or their medical
history was obtained from their families. Trained physicians
reviewed medical records in the local clinics and hospitals. In the
cases of deceased participants, their histories were obtained from
their families and=or attending physicians, and medical records
were reviewed. Modiﬁed criteria of the National Survey of
Stroke7 and the WHO Expert Committee9 were used for the
diagnoses of coronary heart disease and stroke, respectively. The
CT and=or MRI images were available in approximately 60% of
stroke cases in the 1980s and over 90% thereafter, and these
images were used to classify the cases into subtypes based on the
aﬀected site.8
First publication
The ﬁrst CIRCS-related paper was published in 1964 reporting
the ﬁndings of health examination in two areas of Akita
prefecture (Ikawa and Yuri) and two areas of Osaka prefecture
(Akegawa area in Yao and Nose).19 At that time, moderate-to-
severe hypertension was more prevalent in Akita than in Osaka:
the prevalence of hypertension deﬁned using WHO criteria
(systolic blood pressure ≥160mmHg or diastolic blood pressure
≥95mmHg) was around 25% in Akita and around 10% in Osaka
among residents aged 40–54 years. Among those aged 55–64
years, the corresponding prevalence was around 50% in Akita and
around 30% in Osaka. Moreover, in both areas, half of moderate-
to-severe hypertension was categorized into severe hypertension
(systolic blood pressure ≥180mmHg or diastolic blood pressure
≥110mmHg). Such a large diﬀerence in blood pressure levels
between Akita and Osaka suggested a large regional diﬀerence
in annual incidence rate of stroke, which was indeed reported
several years later.20 The annual incidence rate of stroke was
about 2-fold higher in Akita than that in Osaka: among residents
aged 40–69 years, the annual incidence rate was 5.0 cases=1,000
population in Nose (Osaka), 5.6 cases=1,000 population in Yao
(Osaka), 10.4 cases=1,000 population in Ikawa (Akita), and 12.3
cases=1,000 population in Yuri (Akita). This regional inequality
regarding stroke incidence justiﬁed the need for intensive
intervention programs for stroke, especially in Akita.
Most cited papers
Two decades after the establishment of CIRCS, the time trend of
CVD incidence and its risk factors in Ikawa, a rural town of Akita
prefecture between 1964–68 and 1979–83 was reported by
Shimamoto et al,11 which is the most cited paper from CIRCS.
That study was updated up to 2003 and expanded to include a
district of Yao City, Osaka Prefecture, a suburban area of mid-
western Japan.15 In both Ikawa and Yao, the age-adjusted annual
incidence of total stroke (cases=1,000 population) among both
men and women aged 40–69 years was declining through 2003:
these ﬁgures changed from 9.7 for men and 4.2 for women in
1964–1971 to 2.3 for men and 1.1 for women in 1996–2003 in
Ikawa; and from 2.7 for men and 1.3 for women to 1.2 for men
and 0.8 for women in Yao, respectively (Figure 2A). Regarding
coronary heart disease, the age-adjusted incidence in Ikawa
decreased slightly through 2003, but the trend was not statistically
signiﬁcant due to the low incidence (Figure 2B). In contrast to
Ikawa, the incidence of coronary heart disease in Yao signi-
ﬁcantly increased among men (from 0.6 cases=1,000 population
Yamagishi K, et al.
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Figure 2. Trends for age-adjusted incidence of stroke (A), coronary heart disease (B) and blood pressure levels (C). *P < 0.05,
**P < 0.01, and ***P < 0.001 for diﬀerences between Akita and Osaka. (Modiﬁed from Kitamura, et al. J Am Coll
Cardiol 2008;52:71–79)
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in 1980–1987 to 1.3 cases=1,000 population in 1996–2003). In
terms of traditional cardiovascular risk factors, systolic and
diastolic blood pressure levels (Figure 2C) and the proportion of
patients with hypertension decreased among men and women in
both areas, while mean levels of serum total cholesterol increased.
The proportion of patients with medication use for hypertension
and high cholesterol also increased. Among men, the prevalence
of smoking and heavy drinking declined. During the early period
in Ikawa, serum levels of total protein was elevated, which was in
part reﬂected by an increased daily meat intake from 5.8% of
energy to 7.1% of energy among men aged 40–59 years.11
Other features
One of the most notable features of CIRCS is, again, not only
its usefulness for identifying risk factors for CVD, but also as a
platform for the introduction of prevention programs for CVD
and their risk factors using basic, clinical, epidemiological, and
statistical techniques.
Because CIRCS is a dynamic cohort study, which has
consistently performed baseline surveys and has conducted
CVD surveillance every year since 1963, it has also allowed
for the reporting of trends for stroke and coronary heart disease
incidences and their risk factors11,15,21 and impacts of health
education programs on hypertension22 and hypercholesterole-
mia.23 There follows an introduction to two examples of
prevention programs that grew out of CIRCS. First, in a report
of the eﬀects of a long-term hypertension control program for
stroke prevention in communities24 (Figure 3) that compared two
communities for trends in blood pressure levels and stroke
incidence and prevalence between 1963 and 1987, Ikawa, one
of two communities, received a full range of community-wide
hypertension interventions, while the other had a minimal
intervention. In men, stroke incidence and prevalence declined
in the full-intervention area (Ikawa) more than in the minimal-
intervention community, and diﬀerential trends in systolic blood
pressure levels appeared to explain the larger decline in stroke.
Second, in a report on the cost-eﬀectiveness of this long-term
hypertension control program25 (Figure 4) costs of public health
services and of treatment for patients with hypertension or stroke
in the full-intervention community (Ikawa) and minimal-
intervention communities were compared. It was found that the
program in the full-intervention community became cost saving
13 years after its initiation; the incremental costs reduced by
28,358 Japanese yen per capita over 24 years.
CIRCS has led to the identiﬁcation of several novel risk=
preventive factors for CVD: lipids (eg, serum fatty acids
composition26,27 and high-density lipoprotein (HDL)-cholesterol
particle size28), glucose tolerance (non-fasting blood glucose29,30),
other biochemical factors (serum liver=biliary tract enzymes,31,32
serum homocysteine,33 serum C-reactive protein,34 and adipo-
nectins35), hematological factors (leukocyte counts36), ﬁbrinolytic
factors (plasma ﬁbrinogen37–39), electrocardiographic factors
Figure 3. Trends for age-adjusted incidence of stroke in full and minimal intervention communities. Diﬀerence from the minimal
intervention community: **P < 0.01, ***P < 0.001. (Data from Iso, et al. Stroke 1998;29:1510–1518)
Yamagishi K, et al.
J Epidemiol 2019;29(3):83-91 j 87
(ischemic abnormalities40,41 and Brugada-type electrocardio-
gram42), other physiological factors (carotid atherosclerosis43
and ankle-brachial blood pressure index44), dietary factors
(fat and protein intakes45), psychosomatic factors (depressive
symptoms46), height,47 snoring,48 metabolic syndrome,49,50
chronic kidney disease,51 and subclinical end-organ damage,52
as well as traditional risk factors (eg, alcohol,53–55 smoking,56
blood glucose=diabetes,57,58 blood pressure,1,5,11,59 total-,1,5,11
LDL-,60 non-HDL-61 and HDL-cholesterols,62,63 and triglycer-
ides64,65). Recent reports included risk or preventive factors for
dementia, such as smoking,66 C-reactive protein,67 serum
coenzyme Q10,68 serum α-linoleic acid,69 and retinal vascular
changes.70 Cross-cultural comparison studies of lipids,71–73
hemostatic factors,74–77 serum sialic acid,78 and sleep-disordered
breathing79 with American populations have also been conducted.
CIRCS has also been involved in several international or
domestic collaborative studies, such as the Prospective Studies
Collaboration,80 Fibrinogen Studies Collaboration,80 Emerging
Risk Factors Collaboration,81 Chronic Kidney Disease Prognosis
Consortium,82 Japan Arteriosclerosis Longitudinal Study,83 Japan
Arteriosclerosis Longitudinal Study-Existing Cohorts Combine,84
and Evidence for Cardiovascular Prevention from Observational
Cohorts in Japan Study.85 These studies have contributed to
building evidence on prevention of CVD not only for Japanese,
but also for people across the world.
Historical impact on global and local health
During the past half century, CIRCS has continued to provide
scientiﬁc evidence on issues of public health in Japan. One of the
important ﬁndings that CIRCS showed is that the fact stroke is
preventable via screening and controlling hypertension as well as
through lifestyle modiﬁcations, such as reduction of salt intake,
improvements of nutritional balance, and proper rest and physical
activity. Based on the CIRCS ﬁndings, the Japanese government
launched the ﬁrst stroke prevention program across a few model
municipalities in 1969, which was mainly composed of
hypertension screening.86 Since then, the program was gradually
extended to other municipalities and eventually the cardiovas-
cular screening system was established in 1982 under the Health
and Medical Service Act for the Aged, which made every
municipality responsible for oﬀering screening and preventive
activities.86 Since 2008, a screening system by health insurers has
been conducted, which focuses on prevention and control of
metabolic syndrome under the Act on Assurance of Medical Care
for Elderly People.
The ﬁndings from CIRCS, an ongoing dynamic cohort study,
can be applicable not only to the other East Asian countries, but
also to Southeast Asian and African countries with high stroke and
low coronary heart disease. The CIRCS measures were introduced
by the WHO in 2013 as a model program to defeat stroke.87
This seminal epidemiological study revealed that risk factors
and characteristics of CVD were in part diﬀerent between Japan
and the United States=Europe and that it was necessary to
develop distinct ways of prevention for CVD in the Japanese
context. CIRCS has provided scientiﬁc evidence to aid the
development of national health projects including the basic health
checkup systems aimed at prevention of CVD and promotion of
health in communities.
The CIRCS Investigators
CIRCS has been led by Yoshio Komachi (Professor Emeritus
of University of Tsukuba), Minoru Iida, Hideki Ozawa, the
late Takashi Shimamoto (Professor Emeritus of University of
Tsukuba), the late Masamitsu Konishi (Professor Emeritus
of Ehime University), and Yoshinori Ishikawa. The present
investigators of CIRCS are as follows: Hiroyasu Iso, Hironori
Imano, Renzhe Cui, Isao Muraki, Hiroyuki Noda, and Hiroshige
Jinnnouchi (Osaka University), Masahiko Kiyama, Takeo Okada,
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Figure 4. Cost analyses of the hypertension detection and control program, 1964–1987. X-axis: Time frame of cost analysis (t).
Y-axis: Total cost diﬀerence by year deﬁned as follows: Total cost diﬀerence =
Pt
year¼1964fCAð1 0:04Þyear1964
CB ð1 0:04Þyear1964g, t = 1964–1987, where CA stands for total cost (after adjustment for consumer price index) in the
full intervention community andCB stands for that in the minimal intervention community. Discount rate was 4% per year.
(Reprinted from Yamagishi, et al. J Hypertens 2012;30:1874–1879)
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Yuji Shimizu, Mina Hayama-Terada, and Yasuhiko Kubota
(Osaka Center for Cancer and Cardiovascular Disease
Prevention), Tomoko Sankai, Kazumasa Yamagishi, and Mizuki
Sata (University of Tsukuba), Isao Koyama and Masakazu
Nakamura (National Cerebral and Cardiovascular Center), Isao
Saito (Oita University), Koutatsu Maruyama (Ehime University),
Shinichi Sato (Chiba Prefectural Institute of Public Health),
Mitsumasa Umesawa and Masanori Nagao (Dokkyo Medical
University), Takeshi Tanigawa and Ai Ikeda (Juntendo Uni-
versity), Tetsuya Ohira (Fukushima Medical University), and
Akihiko Kitamura (Tokyo Metropolitan Geriatric Medical
Center).
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